RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA-SWITCH): a randomized, double-blind, double-dummy, active-controlled 26-week trial.

Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA-SWITCH): a randomized, double-blind, double-dummy, active-controlled 26-week trial.

Add to Collection
2016 Dec Others Fist_Author_Year_PM

Full Author : ['Bailey, T S', 'Takacs, R', 'Tinahones, F J', 'Rao, P V', 'Tsoukas, G M', 'Thomsen, A B', 'Kaltoft, M S', 'Maislos, M']
Journal Title : Diabetes, obesity & metabolism
Chapter : Section3
Journal Year : 2016
Cited by : Not Available

AIMS: To confirm superiority on glycaemic control by switching from sitagliptin to liraglutide 1.8 mg/d versus continued sitagliptin. MATERIALS AND METHODS: A randomized, multicentre, double-blind, double-dummy, active-controlled trial across 86 office- o.....

Keywords : ["randomize doubleblind doubledummy activecontrolle trial", "type diabetes liraswitch", "switch", "subject", "sitagliptin", "safety", "liraglutide", "efficacy"]